Guoke Hengtai (301370.SZ): Currently, the company's imported and domestically produced medical instruments revenue accounts for approximately 7:3.

Gelonghui Finance · Nov 27, 2024 19:47

GeLongHui, November 27th | Guoke Hengtai (301370.SZ) stated in investor relations that the current company's ratio of imported to domestically produced medical instruments income is approximately 7:3. In terms of customer expansion, the company's innovative platform model has won wide recognition from customers and has established cooperation with over a hundred top domestic and foreign medical instrument manufacturers. With its nationwide integrated operation capabilities and full chain service capabilities, the company provides manufacturers with high standards of service and high-quality delivery, efficiently meeting the requirements of domestic and foreign customers. Looking ahead, the company will seize market opportunities by leveraging its professional advantages in product services and the reputation established in the industry, actively expanding domestic and foreign customer base.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

国科恒泰(301370.SZ)：目前公司进口与国产医疗器械收入占比约为7:3

Guoke Hengtai (301370.SZ): Currently, the company's imported and domestically produced medical instruments revenue accounts for approximately 7:3.

Risk Disclaimer

Statement